Treatment of the Dumping Syndrome With Lanreotide Autogel®
NCT00543179
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
OTHER
Sponsor class
Conditions
Dumping Syndrome
Interventions
DRUG:
Somatuline (Lanreotide Autogel®)
Sponsor
Radboud University Medical Center